Cargando…

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer: Con

Detalles Bibliográficos
Autor principal:	van der Poel, Henk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Open to Debate Con
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605209/ https://www.ncbi.nlm.nih.gov/pubmed/34825224 http://dx.doi.org/10.1016/j.euros.2021.08.011

Ejemplares similares

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021)

Accuracy Versus Impact: The Referee Verdict on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Staging of Prostate Cancer
por: O'Brien, Jonathan, et al.
Publicado: (2021)

Stage II Seminoma: Why Chemotherapy Should Remain a Standard
por: Naoun, Natacha, et al.
Publicado: (2023)

Thulium YAG is the Best Laser for the Prostate Because of Versatility
por: Herrmann, Thomas R.W., et al.
Publicado: (2022)

There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022)

Primary Tumor Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Knipper, Sophie, et al.
Publicado: (2022)

How To Manage T3b Prostate Cancer in the Contemporary Era: The Benefits of Surgery
por: Peyrottes, Arthur, et al.
Publicado: (2023)

TREXIT Is Now: Should We Abandon the Transrectal Route for Prostate Biopsy? Yes
por: Grummet, Jeremy P., et al.
Publicado: (2021)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Con
por: Kuusk, Teele, et al.
Publicado: (2022)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con
por: Seles, Maximilian, et al.
Publicado: (2021)

TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—No
por: Olivier, Jonathan, et al.
Publicado: (2021)

Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
por: Alsyouf, Muhannad, et al.
Publicado: (2023)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Radiotherapy is the Preferred Primary Tumor Treatment in Oligometastatic Prostate Cancer
por: van Moorselaar, R. Jeroen A., et al.
Publicado: (2022)

High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key
por: Terlizzi, Mario, et al.
Publicado: (2022)

How To Manage T3b Prostate Cancer in the Contemporary Era: Is Radiotherapy the Standard of Care?
por: Achard, Vérane, et al.
Publicado: (2023)

The clinical characteristics of patients with primary non‐prostate‐specific membrane antigen‐expressing prostate cancer on preoperative positron emission tomography/computed tomography
por: Veerman, Hans, et al.
Publicado: (2021)

Advantages of an Intracorporeal W-shaped Neobladder
por: Nouhaud, François-Xavier, et al.
Publicado: (2021)

Cytoreductive Nephrectomy in 2021: Obsolete
por: Meza, Luis, et al.
Publicado: (2021)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended? Of Course Not!
por: Sooriakumaran, Prasanna, et al.
Publicado: (2022)

Nerve-sparing Techniques During Robot-assisted Radical Prostatectomy: Clips or Low-energy Bipolar Coagulation? Low Energy
por: de la Taille, Alexandre
Publicado: (2022)

The oncological characteristics of non‐prostate‐specific membrane antigen (PSMA)‐expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography
por: Veerman, Hans, et al.
Publicado: (2022)

Hormonal Intensification Should Start at the Low-risk Stage in Metastatic Prostate Cancer
por: Jazayeri, Seyed Behzad, et al.
Publicado: (2022)

Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging
por: Meijer, Dennie, et al.
Publicado: (2021)

Making the Case for Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography/Computed Tomography in Suspected Prostate Cancer
por: Singh, Harmandeep
Publicado: (2020)

Which is the Best Laser for Treatment of Benign Prostatic Hyperplasia?
por: Scoffone, Cesare Marco, et al.
Publicado: (2022)

Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic Review
por: McGeorge, Stephen, et al.
Publicado: (2021)

Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
por: Inubushi, Masayuki, et al.
Publicado: (2020)

Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop
por: Gupta, Manoj, et al.
Publicado: (2018)

Prostate-specific membrane antigen (PSMA)–ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
por: Tateishi, Ukihide
Publicado: (2020)

Online Prostate-Specific Membrane Antigen and Positron Emission Tomography–Guided Radiation Therapy for Oligometastatic Prostate Cancer
por: Hrinivich, William T., et al.
Publicado: (2019)

Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy
por: Zand, Ladan, et al.
Publicado: (2023)

Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan
por: Agarwal, Krishan Kant, et al.
Publicado: (2016)

Upcoming Role of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Detecting Occult Metastases in Prostate Cancer
por: Gupta, Parul, et al.
Publicado: (2019)

Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
por: Gupta, Manoj, et al.
Publicado: (2020)

Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
por: Heetman, Joris G., et al.
Publicado: (2022)

Primary Tumour Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Ting, Francis, et al.
Publicado: (2022)

How To Manage T3b Prostate Cancer in the Contemporary Era: Referee Position
por: Bossi, Alberto, et al.
Publicado: (2023)

Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis
por: Woo, Sungmin, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia
por: Song, Rachel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gn4rav81mbpgnf968hbb32rra7